Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Comparison of Intraoperative Intravenous Lidocaine Infusion and Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia Following Laproscopic Cholecystectomy

ID
Name
5515
Description
This study is aimed to determine the post operative pain after laparoscopic cholecystectomy by dividing patients into three different group. Group A will receive lidocaine 2mg/kg bolus at induction followed by 1.5mg/kg/hr infusion. Group B will receive bilateral subcostal TAP block with 0.375% 20ml Ropivicaine on each side. Group C will not receive any additional pain regime apart from the routine intraoperative analgesics. Pain score will be assessed post operatively for 24 hours at regular intervals using visual analog score.
Trial arms
Trial start
2022-02-25
Estimated PCD
2022-10-17
Trial end
2022-10-17
Status
Completed
Treatment
Lidocaine IV
Bolus and infusion of lidocaine will be administered
Arms:
Lidocaine Group
Ropivacaine
Bilateral TAP block will be given to these patients
Arms:
TAP group
Size
90
Primary endpoint
Pain score
On arrival in PACU (0 hours)
Pain score
At 2 hours
Pain score
At 4 hours
Pain score
At 6 hours
Pain score
At 12 hours
Pain Score
At 24 hours
Eligibility criteria
Inclusion Criteria: * Age group (18-65) * Undergoing elective Laproscopic Cholecystectomy * ASA status I or II Exclusion Criteria: * Participation in any other trial * Known hypersensitivity to study medications * Chronic Opioid used * Seizure disorder
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 90, 'type': 'ACTUAL'}}
Updated at
2024-06-26

1 organization

2 products

1 indication

Organization
Aga Khan University Hospital
Product
Lidocaine
Indication
Postoperative Pain
Product
Ropivacaine